Canadian Diabetes & Endocrinology Today
Low Risk for Recurrence of Differentiated Thyroid Cancer: A Paradigm Shift to De-Escalation and Simplifying Care for Long Term Follow-up
The incidence of thyroid cancer in Canada increased from 1984 to 2013, followed by a subsequent decline; the most recent projections estimate 6,100 cases in 2026. Low-risk differentiated thyroid cancer (DTC), with an excellent treatment response, is associated with a recurrence risk of less than 2% and a 20-year disease specific mortality of less than 1%. In alignment with the 2025 American Thyroid Association DTC Guidelines and the Follow-up and Transition of Care for Low Recurrence Risk Thyroid Cancer Patients in …